Primary Sjogren Syndrome: Clinical Trials

4 trials for Primary Sjogren Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Phase 4, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1
Not applicable1Completed 1
Phase 21Completed 1

Follow Primary Sjogren Syndrome: new trials by email Literature Review of Primary Sjogren Syndrome trials Research Report on Primary Sjogren Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
Fractional CO2 laser (vaginal), Promestriene Vaginal - Sjogren Syndrome, Sjogren Disease
Phase 4RecruitingUniversity of Sao Paulo General Hospital602026-02-272026-03-03
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
VAY736, Placebo - Primary Sjogren Syndrome
Phase 2CompletedNovartis Pharmaceuticals1902017-06-272025-01-07
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
Lasertherapy, Sham Lasertherapy - KERATOCONJUNCTIVITIS SICCA, XEROSTOMIA
Not applicableCompletedFederal University of São Paulo662014-05-012017-08-03
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Restasis, Refresh Endura - Primary Sjogren Syndrome, Secondary Sjogren Syndrome
Phase 4CompletedFederal University of São Paulo1002013-01-012020-09-22

Narrower conditions

Sjogren's Syndrome (2)  ·  Dry Eye Syndromes (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Xerostomia (1)

Broader conditions

Eye Diseases (3)  ·  Lacrimal Apparatus Diseases (3)  ·  Arthritis (2)  ·  Arthritis, Rheumatoid (2)  ·  Autoimmune Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Dry Eye Syndromes (2)  ·  Immune System Diseases (2)  ·  Joint Diseases (2)  ·  Mouth Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Rheumatic Diseases (2)  ·  Salivary Gland Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Stomatognathic Diseases (2)

Interventions

Castor Oil (1)  ·  Cyclosporins (1)  ·  ianalumab (1)

Sponsors

Federal University of São Paulo (2)  ·  Novartis Pharmaceuticals (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (3)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Chile (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Romania (1)

Top investigators

Rossen M Hazarbassanov, PhD (1)  ·  Virginia M Trevisani, PhD (1)

Results publications

PMID 29119483, PMID 34861168, PMID 39557617